Cargando…

Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related deaths worldwide, primarily due to its propensity for metastasis. Patients diagnosed with localized primary cancer have higher survival rates than those with metastasis. Thus, it is imperative to discover biomar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Bin, Que, Zujun, Lu, Xinyi, Qi, Dan, Qiao, Zhi, Yang, Yun, Qian, Fangfang, Jiang, Yi, Li, Yan, Ke, Ronghu, Shen, Xiaoyun, Xiao, Hua, Li, Hegen, Wu, Erxi, Tian, Jianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641949/ https://www.ncbi.nlm.nih.gov/pubmed/37953280 http://dx.doi.org/10.1186/s12575-023-00223-0

Ejemplares similares

Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation
por: Que, Zujun, et al.
Publicado: (2023)

Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells
por: Que, Zujun, et al.
Publicado: (2019)

Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway: Anti-metastatic mechanism of Jinfukang on lung cancer
por: Yang, Yun, et al.
Publicado: (2023)

New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
por: Que, Zujun, et al.
Publicado: (2022)

Forging the future of circRNA therapeutics: Unleashing synthetic potential and conquering challenges
por: Qi, Dan, et al.
Publicado: (2023)

Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies
por: Wu, Erxi, et al.
Publicado: (2023)

Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
por: Luo, Bin, et al.
Publicado: (2022)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
por: Kim, Dong Ha, et al.
Publicado: (2023)

Identification of a panel of genes as a prognostic biomarker for glioblastoma
por: Wang, Fengfei, et al.
Publicado: (2018)

Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma
por: Yang, Jingwen, et al.
Publicado: (2022)

Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer
por: Sun, Zujun, et al.
Publicado: (2021)

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
por: Que, Zujun, et al.
Publicado: (2019)

Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease
por: Jiang, Ruilai, et al.
Publicado: (2019)

Serum exosome microRNA panel as a noninvasive biomarker for molecular diagnosis of fulminant myocarditis
por: Zhang, Yingying, et al.
Publicado: (2020)

Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer
por: Chang, Wenjing, et al.
Publicado: (2023)

A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules
por: Liang, Meihua, et al.
Publicado: (2020)

A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
por: Zhang, Zhanxia, et al.
Publicado: (2021)

Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer
por: Han, Lei, et al.
Publicado: (2021)

Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer
por: Zhang, Shujun, et al.
Publicado: (2018)

Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
por: Zhang, Li, et al.
Publicado: (2016)

Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
por: Zhu, Lei, et al.
Publicado: (2019)

A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values
por: Jin, Guang-Zhi, et al.
Publicado: (2013)

Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
por: Chen, Chen, et al.
Publicado: (2022)

Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening
por: Dou, Yuhong, et al.
Publicado: (2018)

Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study
por: Makler, Amy, et al.
Publicado: (2023)

Exosome-based small RNA delivery: Progress and prospects
por: Lu, Mei, et al.
Publicado: (2018)

Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study
por: Wu, Baojin, et al.
Publicado: (2021)

Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
por: Liu, Qingyun, et al.
Publicado: (2016)

Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma
por: Sun, Li, et al.
Publicado: (2021)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Exosomal miR-320e as a Novel Potential Biomarker for Cerebral Small Vessel Disease
por: Gao, Ke-Jin, et al.
Publicado: (2023)

A circulating exosomal microRNA panel as a novel biomarker for monitoring post‐transplant renal graft function
por: Chen, Yimeng, et al.
Publicado: (2020)

Tumor‐derived exosomal proteins as diagnostic biomarkers in non‐small cell lung cancer
por: Niu, Limin, et al.
Publicado: (2018)

Circulating exosomal small RNAs are promising non‐invasive diagnostic biomarkers for gastric cancer
por: Ge, Lichen, et al.
Publicado: (2020)

Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer
por: Sandfeld-Paulsen, B., et al.
Publicado: (2016)

Circulating exosomes contain protein biomarkers of metastatic non‐small‐cell lung cancer
por: Wang, Ning, et al.
Publicado: (2018)

Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis
por: Nie, Song, et al.
Publicado: (2014)

Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus
por: Li, Wengen, et al.
Publicado: (2020)

Identification of BAG5 as a Potential Biomarker for Parkinson’s Disease Patients With R492X PINK1 Mutation
por: Fu, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_st8i3g47s4647uju6lddue4vm9